Tower Research Capital LLC (Trc) Innoviva, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Innoviva, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,834 shares of INVA stock, worth $54,271. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,834
Previous 14,847
80.91%
Holding current value
$54,271
Previous $243,000
77.78%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding INVA
# of Institutions
229Shares Held
79.2MCall Options Held
37.6KPut Options Held
300-
Black Rock Inc. New York, NY9.63MShares$184 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT7.28MShares$139 Million34.93% of portfolio
-
Franklin Resources Inc San Mateo, CA6.75MShares$129 Million0.04% of portfolio
-
Putnam Investments LLC Boston, MA6.27MShares$120 Million0.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.23MShares$119 Million0.0% of portfolio
About Innoviva, Inc.
- Ticker INVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,706,000
- Market Cap $1.33B
- Description
- Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...